Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 5,038 |
|
|||||
| News | - |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celularity Inc | CELUW | NASDAQ | Equity Warrant |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.004 | -8.89% | 0.041 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0414 | 0.0409 | 0.0414 | 0.041 | 0.045 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume |
|---|---|---|---|---|
| 20 | 5,038 | 0.0410117 | 207 | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 270 | 0.041 | USD |
Celularity Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.72M | 193.78M | - | 22.77M | -196.3M | -1.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Celularity
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products GlobeNewswire Inc. •
Tue Feb 25, 2025 8:00 AM (5 days ago)
Form 8-K - Current report Edgar (US Regulatory) •
Mon Feb 24, 2025 9:00 AM (6 days ago)
Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company GlobeNewswire Inc. •
Mon Feb 24, 2025 8:00 AM (6 days ago)
Form 4 - Statement of changes in beneficial ownership of securities Edgar (US Regulatory) •
Wed Feb 19, 2025 5:50 PM (2 weeks ago)
Form 4 - Statement of changes in beneficial ownership of securities Edgar (US Regulatory) •
Wed Feb 19, 2025 5:00 PM (2 weeks ago)
Form 4 - Statement of changes in beneficial ownership of securities Edgar (US Regulatory) •
Wed Feb 19, 2025 5:00 PM (2 weeks ago)
Form 8-K - Current report Edgar (US Regulatory) •
Tue Feb 18, 2025 8:45 AM (2 weeks ago)
Form EFFECT - Notice of Effectiveness Edgar (US Regulatory) •
Tue Feb 18, 2025 12:15 AM (2 weeks ago)
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Edgar (US Regulatory) •
Thu Feb 13, 2025 6:23 AM (2 weeks ago)
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] Edgar (US Regulatory) •
Thu Feb 13, 2025 6:20 AM (2 weeks ago)
Form S-1 - General form for registration of securities under the Securities Act of 1933 Edgar (US Regulatory) •
Thu Jan 30, 2025 5:31 PM (1 month ago)
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] Edgar (US Regulatory) •
Tue Jan 28, 2025 4:30 PM (1 month ago)
CELUW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. |
NASDAQ:CELUW -
What is the current Celularity Inc share price?
The current share price of Celularity Inc is $ 0.041
How many Celularity Inc shares are in issue?
Celularity Inc has 193,782,000 shares in issue
What is the market cap of Celularity Inc?
The market capitalisation of Celularity Inc is USD 8.72M
What is the 1 year trading range for Celularity Inc share price?
Celularity Inc has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Celularity Inc?
The price to earnings ratio of Celularity Inc is -10.07
What is the cash to sales ratio of Celularity Inc?
The cash to sales ratio of Celularity Inc is 86.81
What is the reporting currency for Celularity Inc?
Celularity Inc reports financial results in USD
What is the latest annual turnover for Celularity Inc?
The latest annual turnover of Celularity Inc is USD 22.77M
What is the latest annual profit for Celularity Inc?
The latest annual profit of Celularity Inc is USD -196.3M
What is the registered address of Celularity Inc?
The registered address for Celularity Inc is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Celularity Inc website address?
The website address for Celularity Inc is www.celularity.com
Which industry sector does Celularity Inc operate in?
Celularity Inc operates in the PHARMACEUTICAL PREPARATIONS sector
